A Phase IIb randomised controlled trial of the safety, immunogenicity and efficacy of the blood-stage malaria vaccine candidates RH5.1 in Matrix-MTM and RH5.2-VLP in Matrix-MTM in infants aged 5-17 months in Burkina Faso.
We are involved in the Health Research Venture
We are at the forefront of drugs and vaccines trials in Africa
We generate data to improve human health
Our global laboratories can provide diagnostics solutions for clinical trials across Africa and the world.
CRUN performs study and teach in a variety of areas, including policy, epidemiology, behavioral science, diagnostics and pharmaceutical development, clinical trials, and bench science.
With specialist research groups research at CRUN focuses on structural biology, molecular cell biology and more.
We currently have no job openings
CRUN is not recruiting for the moment